NeOnc Technologies Holdings, Inc. Common Stock

NTHI XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

89M

Short interest (Jul 15)

2.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

3.73%

↑ 16.6%

Available Shares

70K

↓ 68.4%

Price Chart

Company Overview

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001979414

Asset Type: CS

Market Data

Market Cap: $88,946,296

Employees: 5

Status: Active

Short Interest

Current Borrow Fee 3.73%

Range: 3.58% - 3.73%

Available Shares 70K

Range: 0 - 70K

Recent Changes

Fee Change: ↑ 2.2%

Available Change: ↑ 1230.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime